Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Kim D, Sundling KE, Virk R, Thrall MJ, Alperstein S, Bui MM, et al. Digital cytology part 1: digital cytology implementation for practice: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force. J Am Soc Cytopathol. 2024;13(2):86-96.

Gal J, Mosquera JM, Robinson BD, Schlegel PN. Incidental seminoma in nonobstructive azoospermia: a case report. F S Rep. 2024;5(2):211-213.

O'Neill KA, Dugue A, Abreu NJ, Balcer LJ, Branche M, Galetta S, et al. Relapsing White Matter Disease and Subclinical Optic Neuropathy: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2024;11(2):e200194.

Han Y, Duan X, Yang L, Nilsson-Payant BE, Wang P, Duan F, et al. Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2024;630(8016):E7.

Li Z, Zeng X, Shi B, Han J, Wu Z, Chen X, et al. Schnurri-3 controls osteogenic fate of Adipoq-lineage progenitors in bone marrow. J Orthop Translat. 2024;45:168-177.

Saunders KE, Gerken N, Khani F, Williamson SR, Wobker SE. Current gross examination and reporting patterns of post-neoadjuvant chemotherapy cystectomy specimens: Is it time for a standardized approach? Am J Clin Pathol. 2024.

Torres HM, Marino J, Simon MS, Singh HK, Westblade LF, Calfee DP. High touch surface bioburden associated with the use of disinfectants with and without continuously active disinfection in ambulatory care settings. Infect Control Hosp Epidemiol. 2024:1-3.

Papachristodoulou A, Heidegger I, Virk RK, Di Bernardo M, Kim JY, Laplaca C, et al. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. Eur Urol. 2024;85(4):361-372.

Patel SS. NPM1-Mutated Acute Myeloid Leukemia: Recent Developments and Open Questions. Pathobiology. 2024;91(1):18-29.

Soderquist CR, Freeman C, Lin W-, Leeman-Neill RJ, Gu Y, Carter MC, et al. Clinical Utility and Reimbursement of Next-Generation Sequencing-Based Testing for Myeloid Malignancies. J Mol Diagn. 2024;26(1):5-16.